Literature DB >> 26773724

Extranodal NK/T-cell lymphoma, nasal type, manifesting as rapidly progressive dementia without any mass or enhancing brain lesion.

Yoshimitsu Shimatani1, Yuta Nakano2, Naoko Tsuyama2,3, Shigeo Murayama2, Ryosuke Oki1, Ryosuke Miyamoto1, Nagahisa Murakami1, Koji Fujita1, Syunsuke Watanabe4, Hisanori Uehara4, Takashi Abe5, Hiroyuki Nodera1, Toshitaka Kawarai1, Yuishin Izumi1, Ryuji Kaji1.   

Abstract

Among the many potential etiologies for rapidly progressive dementia (RPD), primary central nervous system extranodal NK/T-cell lymphoma, nasal-type (ENKL) is a rare entity. We present the first reported case of autopsy-proven RPD due to ENKL without any mass or enhancing lesion of the brain. A 54-year-old immunocompetent man presented with RPD, myoclonus and ataxia. The mini-mental state examination (MMSE) score was 22/30. His brain MRI revealed progressive brain atrophy without gadolinium enhancement or mass lesion. Five months after the initial evaluation, cognitive impairment further worsened with an MMSE score of 3/30. At the advanced stage, lumbar MRI showed swollen cauda equina with gadolinium enhancement. The number of Epstein-Barr virus (EBV) DNA in cerebrospinal fluid had gradually increased. Twelve months after onset, the patient died of respiratory failure. Pathological findings revealed that lymphoma cells had diffusely invaded the meninges, parenchyma of the brain, spinal cord and cauda equina. Cells were positive for CD3, CD56 and EBV-encoded small RNAs and negative for CD20. No evidence of malignancy was identified in the visceral organs. This report indicates that ENKL should be recognized as one of the rare causes of RPD. Early testing for EBV-DNA in cerebrospinal fluid and imaging of cauda equina would be useful diagnostic tools.
© 2016 Japanese Society of Neuropathology.

Entities:  

Keywords:  cauda equina; epstein-barr virus; extranodal NK/T-cell lymphoma; nasal type; rapidly progressive dementia

Mesh:

Year:  2016        PMID: 26773724     DOI: 10.1111/neup.12285

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  3 in total

Review 1.  Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.

Authors:  Bradley M Haverkos; Zenggang Pan; Alejandro A Gru; Aharon G Freud; Rachel Rabinovitch; Meng Xu-Welliver; Brad Otto; Carlos Barrionuevo; Robert A Baiocchi; Rosemary Rochford; Pierluigi Porcu
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

2.  Nasal-Type Extranodal Natural Killer/T Cell Lymphoma with Meningeal Involvement: A Case Report and Literature Review.

Authors:  Chunli Yang; Hongyu Zhuo; Liqun Zou
Journal:  Indian J Hematol Blood Transfus       Date:  2019-11-30       Impact factor: 0.900

3.  Successful Treatment of Primary CNS Extranodal NK/T-Cell Lymphoma with Surgery and Chemotherapy Combined with Sintilimab: A Case Report and Literature Review.

Authors:  Liping Qin; Yajun Li; Yizi He; Ruolan Zeng; Tao Pan; Yilang Zuo; Ling Xiao; Hui Zhou
Journal:  Onco Targets Ther       Date:  2022-01-06       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.